BriaCell Therapeutics Corp. (TSX:BCT)
Canada · Delayed Price · Currency is CAD 5.68
-0.06 (-1.05%)
At close: Feb 11, 2026
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 35.65 million as of February 11, 2026. Its market cap has increased by 49.37% in one year.
Market Cap
35.65M
Enterprise Value
20.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.68
Market Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 35.65M, an increase of 46.02%. That is a compound annual growth rate of 3.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 35.28M | 91.10% |
| Dec 31, 2025 | 18.46M | -48.44% |
| Dec 31, 2024 | 35.81M | -71.28% |
| Dec 29, 2023 | 124.66M | 36.15% |
| Dec 30, 2022 | 91.56M | -44.85% |
| Dec 31, 2021 | 166.03M | 3,496.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 58.04M |
| Sernova Biotherapeutics | 49.17M |
| MedMira | 45.33M |
| Defence Therapeutics | 35.00M |
| Resverlogix | 33.09M |
| Thiogenesis Therapeutics | 32.14M |
| Microbix Biosystems | 30.48M |
| Telescope Innovations | 28.28M |